Evaluation of outcomes in renal transplantation with hypothermic machine perfusion for the preservation of kidneys from expanded-criteria donors

A recently released article by Savoye et al. used the data collected by The French National Transplant Registry (CRISTAL) following the implementation of a nationwide hypothermic machine perfusion (HMP) program for extended criteria donor (ECD) kidney transplants.

The study included 4,316 transplants, 801 of which used HMP. Overall, they confirmed that even though the HMP transplant population was at higher risk for delayed graft function (DGF), HMP compared with cold storage (CS) protected against DGF (adjusted OR=0.49 with a 24% DGF rate in the HMP group versus 38% in the CS group).

Read the full article here: https://doi.org/10.1111/ctr.13536

Tagged In:

Clinical, DGF, HMP, Kidney

The Latest

Check out the most recent posts

Fox19—UC Health Performs First Cold Pump Liver Transplant

In this article from FOX19 NOW, meet the first liver transplant patient to receive a cold pump liver which was pumped on a LifePort® Liver Transporter during its clinical trial, PILOT™. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a...

ABC12 News—Organ Transplant Goes Hi-tech

In this article, Intermountain Healthcare takes part in the PILOT™ clinical trial of the LifePort® Liver Transporter. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine...

KSLTV—Doctors Testing New Liver Transplant Transport System

In this article, KSLTV of Salt Lake City reports on Intermountain Healthcare’s participation in the LifePort Liver Transporter clinical trial. “We’re keeping that liver working in a somewhat normal, physiologic state during the time that it’s out of the donor’s body...